DV
Dividend Vision

AQSZF — Aequus Pharmaceuticals Inc

Aequus Pharmaceuticals Inc (AQSZF)

Total return is -99.7% over the past 11.2 years, 444.7 points behind SPY at 345.0%. Its deepest 1-year drawdown was 95.8%.

AQSZF is a healthcare equity holding that tracks a single pharmaceutical stock rather than functioning as a diversified ETF. The fund does not currently maintain an active dividend distribution program, making it unsuitable for income-focused investors seeking regular dividend payments. This concentrated equity position appeals primarily to investors seeking exposure to the pharmaceutical sector through a single-company vehicle, though the lack of diversification carries elevated risk compared to broader healthcare or dividend-focused funds.

AQSZF key facts

Asset type
Stock
Asset class
Equity
Inception date
06/16/2015
Distribution frequency
None
Last close
$0.0012
Market cap
$159,161
Average volume
0.0
Beta
-0.207
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.01